The Information Weekend

Bootleg Reta is Silicon Valley’s Drug of the Summer

Retatrutide hasn't received FDA approval. But tech executives have already embraced a Wild West market for knockoff versions.

By

Longevity Startups Have a Conundrum: Can They Sell Longevity Drugs?

In many ways, these are the best of times for Silicon Valley’s buzziest crop of longevity startups and their pursuit of drugs that can reverse aging. NewLimit, a cell reprogramming company...

By

Amy Dockser Marcus

Politics and Policy

How One Silicon Valley Congressman is Trying Get AI Mega Money Out of Politics

In early April, a staffer for Sam Liccardo, a freshman congressman representing the heart of Silicon Valley, got a call from a reporter telling them he was about to receive an endorsement—from...

By

Leo Schwartz

Congressman Sam Liccardo. Art by Clark Miller

The Big Read

SpaceX’s CFO Is the Quiet VIP of a Wild IPO

Bret Johnsen, SpaceX’s low-profile chief financial officer, has tried to keep a grip over the most frenetic episode in his decade-plus at the company. It will only get crazier from here.

By

Theo Wayt

and

Valida Pau

Tech Culture

SpaceX Millionaires Mull IPO Windfall: A Mansion, a College Fund—or ‘Chill on the Beach’?

SpaceX’s expected IPO next week will mean a banner day for many of Silicon Valley’s biggest names. But given the offering’s stratospheric size—it’s the largest ever stock market debut—it will also...

By

Eli Rosenberg

Space Inc.

SpaceX Mafia Eagerly Track Mega IPO, Hoping for Industrywide Liftoff

SpaceX’s offices in Texas and California may host the most raucous celebrations when the company’s shares start trading this coming Friday—but an extensive network of companies founded by SpaceX...

By

Theo Wayt